Ballentine Partners LLC Has $1.02 Million Holdings in Azenta, Inc. (NASDAQ:AZTA)

Ballentine Partners LLC grew its position in shares of Azenta, Inc. (NASDAQ:AZTA) by 2.0% in the 4th quarter, Holdings Channel reports. The firm owned 20,340 shares of the company’s stock after acquiring an additional 404 shares during the quarter. Ballentine Partners LLC’s holdings in Azenta were worth $1,017,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Farther Finance Advisors LLC raised its stake in Azenta by 20.0% during the third quarter. Farther Finance Advisors LLC now owns 1,537 shares of the company’s stock worth $74,000 after buying an additional 256 shares during the last quarter. Benjamin F. Edwards & Company Inc. raised its position in shares of Azenta by 150.9% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 1,588 shares of the company’s stock worth $84,000 after acquiring an additional 955 shares in the last quarter. Assenagon Asset Management S.A. bought a new stake in shares of Azenta during the 4th quarter valued at about $200,000. Net Worth Advisory Group bought a new stake in shares of Azenta during the 3rd quarter valued at about $205,000. Finally, Aigen Investment Management LP bought a new stake in Azenta in the third quarter worth approximately $214,000. Institutional investors and hedge funds own 99.08% of the company’s stock.

Insiders Place Their Bets

In other news, Director William L. Cornog acquired 12,500 shares of the business’s stock in a transaction on Monday, November 18th. The shares were purchased at an average cost of $39.60 per share, with a total value of $495,000.00. Following the acquisition, the director now directly owns 14,755 shares of the company’s stock, valued at $584,298. The trade was a 554.32 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Herman Cueto sold 712 shares of the stock in a transaction dated Tuesday, November 19th. The shares were sold at an average price of $40.07, for a total transaction of $28,529.84. Following the completion of the sale, the chief financial officer now owns 23,892 shares of the company’s stock, valued at approximately $957,352.44. This represents a 2.89 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 1,423 shares of company stock valued at $57,020. Corporate insiders own 10.62% of the company’s stock.

Azenta Trading Up 0.3 %

NASDAQ AZTA opened at $53.98 on Thursday. The company has a market cap of $2.47 billion, a P/E ratio of -18.18 and a beta of 1.47. The company has a fifty day simple moving average of $48.39 and a 200 day simple moving average of $49.05. Azenta, Inc. has a 12-month low of $38.82 and a 12-month high of $68.54.

Azenta (NASDAQ:AZTA) last posted its earnings results on Tuesday, November 12th. The company reported $0.18 EPS for the quarter, topping the consensus estimate of $0.10 by $0.08. Azenta had a negative net margin of 25.01% and a positive return on equity of 1.03%. The company had revenue of $170.00 million during the quarter, compared to the consensus estimate of $169.66 million. During the same period in the previous year, the firm posted $0.13 earnings per share. The firm’s revenue for the quarter was down 1.2% on a year-over-year basis. Sell-side analysts predict that Azenta, Inc. will post 0.41 EPS for the current year.

Analyst Ratings Changes

AZTA has been the topic of a number of research analyst reports. Needham & Company LLC cut their price target on Azenta from $69.00 to $55.00 and set a “buy” rating on the stock in a report on Wednesday, November 13th. Evercore ISI reduced their price target on shares of Azenta from $53.00 to $50.00 and set an “in-line” rating for the company in a report on Tuesday, October 1st. Finally, Stephens reiterated an “overweight” rating and set a $60.00 price objective on shares of Azenta in a report on Thursday, January 2nd. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $61.60.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.